These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37745627)

  • 1. Effect of elevated temperature on SARS-CoV-2 viability.
    Harapan H; Johar E; Maroef CN; Sriyani IY; Iqhrammullah M; Kusuma HI; Syukri M; Razali R; Hamdani H; Kurniawan R; Irwansyah I; Sofyan SE; Myint KS; Mahlia TMI; Rizal S
    F1000Res; 2022; 11():403. PubMed ID: 37745627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the rationale for thermotherapy in COVID-19.
    Mancilla-Galindo J; Galindo-Sevilla N
    Int J Hyperthermia; 2021; 38(1):202-212. PubMed ID: 33682604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting stability and infectivity of SARS-CoV-2.
    Chan KH; Sridhar S; Zhang RR; Chu H; Fung AY; Chan G; Chan JF; To KK; Hung IF; Cheng VC; Yuen KY
    J Hosp Infect; 2020 Oct; 106(2):226-231. PubMed ID: 32652214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid thermal inactivation of aerosolized SARS-CoV-2.
    Canpolat M; Bozkurt S; Şakalar Ç; Çoban AY; Karaçaylı D; Toker E
    J Virol Methods; 2022 Mar; 301():114465. PubMed ID: 35033579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Activity of the Propylamylatin
    Brown AN; Strobel G; Hanrahan KC; Sears J
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33807769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 infection: the environmental endurance of the virus can be influenced by the increase of temperature.
    Magurano F; Baggieri M; Marchi A; Rezza G; Nicoletti L;
    Clin Microbiol Infect; 2021 Feb; 27(2):289.e5-289.e7. PubMed ID: 33161149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ambient temperature on respiratory tract cells exposed to SARS-CoV-2 viral mimicking nanospheres-An experimental study.
    Kumar S; Paul A; Chatterjee S; Pütz S; Nehra N; Wang DS; Nisar A; M Jennings C; Parekh SH
    Biointerphases; 2021 Jan; 16(1):011006. PubMed ID: 33706521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and detection of SARS-CoV-2 variants on dry swabs post storage.
    Gordhan BG; Ealand CS; Kana BD
    Front Cell Infect Microbiol; 2022; 12():1031775. PubMed ID: 36467724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
    Herder V; Dee K; Wojtus JK; Epifano I; Goldfarb D; Rozario C; Gu Q; Da Silva Filipe A; Nomikou K; Nichols J; Jarrett RF; Stevenson A; McFarlane S; Stewart ME; Szemiel AM; Pinto RM; Masdefiol Garriga A; Davis C; Allan J; Graham SV; Murcia PR; Boutell C
    PLoS Biol; 2021 Dec; 19(12):e3001065. PubMed ID: 34932557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extent of infectious SARS-CoV-2 shedding in an Argentinean cohort.
    Blanco S; Aguilar JJ; Konigheim BS; Diaz LA; Spinsanti L; Beranek M; Collino C; ; Diaz M; Barbás MG; Gallego SV
    J Public Health (Oxf); 2021 Sep; 43(3):e482-e486. PubMed ID: 33963399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conditions for SARS-CoV cultivation and inactivation].
    Zhang SL; Ma LJ; Tian G; Zhang LY; Zhang XY; Wang XL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):135-7. PubMed ID: 16027779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
    Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Intensity Ultraviolet-C Irradiation Efficiently Inactivates SARS-CoV-2 Under Typical Cold Chain Temperature.
    Li P; Ke X; Leng D; Lin X; Yang W; Zhang H; Tian C; Xu H; Chen Q
    Food Environ Virol; 2023 Jun; 15(2):123-130. PubMed ID: 36890342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro.
    Lee G; Budhathoki S; Lee GY; Oh KJ; Ham YK; Kim YJ; Lim YR; Hoang PT; Lee Y; Lim SW; Kim JM; Cho S; Kim TH; Song JW; Lee S; Kim WK
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33918914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Holder pasteurization of donated human milk is effective in inactivating SARS-CoV-2.
    Unger S; Christie-Holmes N; Guvenc F; Budylowski P; Mubareka S; Gray-Owen SD; O'Connor DL
    CMAJ; 2020 Aug; 192(31):E871-E874. PubMed ID: 32646870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of SARS-CoV-2 in Viral Cell Culture in Immunocompromised Patients With Persistently Positive RT-PCR Results.
    Sung A; Bailey AL; Stewart HB; McDonald D; Wallace MA; Peacock K; Miller C; Reske KA; O'Neil CA; Fraser VJ; Diamond MS; Burnham CD; Babcock HM; Kwon JH
    Front Cell Infect Microbiol; 2022; 12():804175. PubMed ID: 35186791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates.
    Mollan KR; Eron JJ; Krajewski TJ; Painter W; Duke ER; Morse CG; Goecker EA; Premkumar L; Wolfe CR; Szewczyk LJ; Alabanza PL; Loftis AJ; Degli-Angeli EJ; Brown AJ; Dragavon JA; Won JJ; Keys J; Hudgens MG; Fang L; Wohl DA; Cohen MS; Baric RS; Coombs RW; Sheahan TP; Fischer WA
    Clin Infect Dis; 2022 Aug; 75(1):e1028-e1036. PubMed ID: 35022711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.